S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Estonia to buy US rocket artillery system in $200M deal
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Moldova signs new energy deal that could ease blackout risk
Tennessee roads plan mulls toll lanes, electric car fee hike
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Estonia to buy US rocket artillery system in $200M deal
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Moldova signs new energy deal that could ease blackout risk
Tennessee roads plan mulls toll lanes, electric car fee hike
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Estonia to buy US rocket artillery system in $200M deal
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Moldova signs new energy deal that could ease blackout risk
Tennessee roads plan mulls toll lanes, electric car fee hike
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Estonia to buy US rocket artillery system in $200M deal
Russia rejects $60-a-barrel cap on its oil, warns of cutoffs
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Ukraine urges tougher Western squeeze on Russian oil prices
UK arrests wealthy Russian as police target Putin enablers
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Moldova signs new energy deal that could ease blackout risk
Tennessee roads plan mulls toll lanes, electric car fee hike
NASDAQ:BRKR

Bruker - BRKR Stock Forecast, Price & News

$66.92
-0.76 (-1.12%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$66.23
$67.49
50-Day Range
$48.91
$69.91
52-Week Range
$48.42
$85.42
Volume
303,605 shs
Average Volume
607,867 shs
Market Capitalization
$9.84 billion
P/E Ratio
36.57
Dividend Yield
0.30%
Price Target
$74.00

Bruker MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
10.6% Upside
$74.00 Price Target
Short Interest
Healthy
2.91% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.48
Upright™ Environmental Score
News Sentiment
0.58mentions of Bruker in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.66%
From $2.31 to $2.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.86 out of 5 stars

Computer And Technology Sector

60th out of 633 stocks

Analytical Instruments Industry

1st out of 28 stocks

BRKR stock logo

About Bruker (NASDAQ:BRKR) Stock

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) Life Science, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI Life Science segment includes enabling life science tools based on magnetic resonance technology. The BSI Nano segment offers x-ray instruments that use electromagnetic radiation with wavelengths to determine the characteristics of matter and the three-dimensional (3D) structure of molecules. The BEST segment consists of conducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications. The company was founded by Gunther Laukien in 1960 and is headquartered in Billerica, MA.

Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Stock News Headlines

Bruker Co. (NASDAQ:BRKR) Announces Quarterly Dividend of $0.05
Bruker Third Quarter 2022 Earnings: Beats Expectations
Bruker Reports Third Quarter 2022 Financial Results
Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates
Bruker (NASDAQ: BRKR)
Bruker is Now Oversold (BRKR) - Nasdaq
See More Headlines
Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Company Calendar

Last Earnings
11/01/2021
Ex-Dividend for 9/16 Dividend
8/31/2022
Dividend Payable
9/16/2022
Ex-Dividend for 12/16 Dividend
11/30/2022
Today
12/03/2022
Dividend Payable
12/16/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/10/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:BRKR
CUSIP
11679410
Employees
7,765
Year Founded
1960

Price Target and Rating

Average Stock Price Forecast
$74.00
High Stock Price Forecast
$85.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+10.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$277.10 million
Pretax Margin
16.46%

Debt

Sales & Book Value

Annual Sales
$2.42 billion
Cash Flow
$2.67 per share
Book Value
$6.45 per share

Miscellaneous

Free Float
106,488,000
Market Cap
$9.84 billion
Optionable
Optionable
Beta
1.21

Social Links


Key Executives

  • Frank H. LaukienFrank H. Laukien
    Chairman, President & Chief Executive Officer
  • Gerald N. Herman
    Chief Financial Officer & Executive Vice President
  • Mark Robert Munch
    Executive Vice President
  • Jürgen Srega
    Group President-Bruker CALID Segment
  • Falko Busse
    President-Bruker BioSpin Group













BRKR Stock - Frequently Asked Questions

Should I buy or sell Bruker stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BRKR shares.
View BRKR analyst ratings
or view top-rated stocks.

What is Bruker's stock price forecast for 2023?

4 analysts have issued 12 month target prices for Bruker's shares. Their BRKR share price forecasts range from $60.00 to $85.00. On average, they predict the company's share price to reach $74.00 in the next year. This suggests a possible upside of 10.6% from the stock's current price.
View analysts price targets for BRKR
or view top-rated stocks among Wall Street analysts.

How have BRKR shares performed in 2022?

Bruker's stock was trading at $83.91 at the beginning of 2022. Since then, BRKR stock has decreased by 20.2% and is now trading at $66.92.
View the best growth stocks for 2022 here
.

When is Bruker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 10th 2023.
View our BRKR earnings forecast
.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) issued its quarterly earnings results on Monday, November, 1st. The medical research company reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.44 by $0.19. The medical research company earned $608.90 million during the quarter, compared to analyst estimates of $575.33 million. Bruker had a trailing twelve-month return on equity of 32.58% and a net margin of 10.97%. The firm's quarterly revenue was up 19.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.42 earnings per share.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker announced a quarterly dividend on Friday, November 11th. Stockholders of record on Thursday, December 1st will be given a dividend of $0.05 per share on Friday, December 16th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date is Wednesday, November 30th.
Read our dividend analysis for BRKR
.

Is Bruker a good dividend stock?

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.30%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 10.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.97% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided EPS guidance of $2.29-$2.33 for the period, compared to the consensus estimate of $2.29. The company issued revenue guidance of $2.45 billion-$2.50 billion, compared to the consensus revenue estimate of $2.50 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.47%), Vanguard Group Inc. (7.45%), Massachusetts Financial Services Co. MA (4.88%), Alliancebernstein L.P. (2.19%), State Street Corp (2.13%) and Price T Rowe Associates Inc. MD (2.11%). Insiders that own company stock include Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends
.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $66.92.

How much money does Bruker make?

Bruker (NASDAQ:BRKR) has a market capitalization of $9.84 billion and generates $2.42 billion in revenue each year. The medical research company earns $277.10 million in net income (profit) each year or $1.83 on an earnings per share basis.

How many employees does Bruker have?

The company employs 7,765 workers across the globe.

Does Bruker have any subsidiaries?
The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More
How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for the company is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.

This page (NASDAQ:BRKR) was last updated on 12/4/2022 by MarketBeat.com Staff